Israeli Patent Issued in Bard1 Core Patent Family
Filed with ASX · · 2 pages · English
Story so far
Earlier from Inoviq
- Additional BARD1 Ovarian Test Results
- Grant of Japanese Patent
- Results of BARD1 ovarian cancer study
- Research and Development Update
- Appendix 4E Preliminary Financial Results
Later from Inoviq
- Capital Raising
- Voluntary Suspension
- Contract Development Agreement Signed
- Improved Performance of BARD1 Ovarian Test
- US Patent Issued Protecting BARD1 Ovarian Test
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq